Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A non-AUG translational initiation event generates novel WT1 isoforms

W Bruening1, J Pelletier

  • 1Department of Biochemistry, McGill University, 3655 Drummond St., Montreal, Quebec H3G 1Y6, Canada.

The Journal of Biological Chemistry
|April 12, 1996
PubMed
Summary

Researchers discovered novel, larger WT1 protein isoforms in normal and Wilms tumor tissues. These isoforms originate from a different start codon, suggesting more complex gene regulation with implications for urogenital development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Time is Brain" also in multiple sclerosis: Fifteen years later, a fully consolidated concept.

Revue neurologique·2026
Same author

Immune checkpoint inhibitor - associated optic neuropathy: Two illustrative cases and therapeutic implications.

Revue neurologique·2026
Same author

Long-interval dosing of anti-CD20 therapy: Toward affordable treatment for multiple sclerosis.

Revue neurologique·2026
Same author

Osteopathic manipulation and its applicability in the emergency department: A narrative review.

The American journal of emergency medicine·2024
Same author

Contribution of the MP2RAGE 7T Sequence in MS Lesions of the Cervical Spinal Cord.

AJNR. American journal of neuroradiology·2023
Same author

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022

Area of Science:

  • Molecular Biology
  • Genetics
  • Developmental Biology

Background:

  • The Wilms' tumor (WT) suppressor gene, WT1, is crucial for urogenital system development and is implicated in a subset of Wilms tumors.
  • WT1 gene expression involves multiple transcriptional start sites and alternative splicing, leading to known protein isoforms.

Purpose of the Study:

  • To identify and characterize novel WT1 protein isoforms.
  • To investigate the origin and function of these newly identified isoforms.
  • To understand the implications for WT1 gene regulation and urogenital development.

Main Methods:

  • Mutational analysis of murine wt1 mRNA.
  • Identification and characterization of novel protein isoforms using molecular techniques.
  • Localization studies within cells.

Related Experiment Videos

  • Transcriptional repression assays.

    • Main Results:

    • Identification of novel WT1 protein isoforms with predicted molecular masses of 54-56 kDa.
    • Demonstration that these larger isoforms result from translation initiation at a CUG codon upstream of the canonical AUG.
    • Confirmation of the presence of these novel isoforms in both normal murine tissues and Wilms tumors.
    • Evidence that the larger isoforms, like canonical WT1, localize to the nucleus and exhibit transcriptional repression activity.

    Conclusions:

    • WT1 gene expression regulation is more complex than previously understood, involving alternative translation initiation.
    • The newly identified WT1 isoforms are present in both normal development and disease states (Wilms tumors).
    • These findings have significant implications for understanding normal and abnormal urogenital system development.